Water purification firm Nephros Q2 revenue beats street view

Nephros

07/08/2025 21:11

Overview

Nephros Q2 revenue rises 36% yr/yr, beating analyst expectations, per LSEG data

Company achieves profitability with Q2 net income of $237,000

Outlook

Nephros expects sustained growth due to strategic focus and market-leading technology

Company sees durable demand reinforcing confidence in long-term outlook

Result Drivers

PROGRAMMATIC SALES - Strong reorders and new active sites drove a 31% increase in core programmatic revenue

DIALYSIS WATER SEGMENT - Achieved second-highest performance on record and secured largest filtration purchase order in company history

GROSS MARGIN IMPROVEMENT - Reduction in shipping costs and inventory reserve adjustments led to higher gross margins

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$4.40 mln
$3.65 mln (2 Analysts)
Q2 Gross Margin
63.0%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the environmental services & equipment peer group is "buy"

Wall Street's median 12-month price target for Nephros Inc is $4.75, about 36.8% above its August 6 closing price of $3.00

The stock recently traded at 384 times the next 12-month earnings vs. a P/E of 75 three months ago

Press Release: ID:nGNXbyLc2s

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)